HLVX - HilleVax, Inc.

Analysis of HilleVax, Inc.(HLVX), HilleVax, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializin

HilleVax, Inc.

HLVX

NASDAQ

HilleVax, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel vaccines. It is developing HIL-214, a virus-like particle-based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis caused by norovirus infection. The company is headquartered in Boston, Massachusetts.

13.28 USD

0.49 (3.69%)

Overview Profile Financial Statements Financial Ratios Chart Analysis News Corporate Actions DCF

Upgrades & Downgrades

We are unable to load this data!

Price PriceTargets

We are unable to load the data!

FMP

Home Terms of Service Privacy Policy Blog FAQs Contact Us

API

Documentation Pricing Formulas Market Indexes

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.